Found 45 matching trials
A Study to Investigate the Effect of Impaired Hepatic Function on the Pharmacokinetics of Entrectinib in Volunteers With Different Levels of Hepatic Function PHASE1 This is a non-randomized, open-label, one treatment, four group, parallel g...
Show More Location
Pharmaceutical Research Associates CZ, s.r.o.
Learn More & Join Trial
The Finnish National Study to Facilitate Patient Access to Targeted Anti-cancer Drugs PHASE2 This is a prospective non-randomized national clinical phase 2 trial that a...
Show More Location
Turku University Hospital Cancer Centre
Learn More & Join Trial
Precise Local Injection of Anti-cancer Drugs Using Presage's CIVO Device in Soft Tissue Sarcoma PHASE1 This is a feasibility study in patients with localized or metastatic soft t...
Show More Location
Monter Cancer Center (Northwell Health)
Learn More & Join Trial
Improving Public Cancer Care by Implementing Precision Medicine in Norway PHASE2 IMPRESS-Norway is a prospective, non-randomized clinical trial evaluating e...
Show More Location
Sykehuset Ålesund
Learn More & Join Trial
Study of PAC-1 and Entrectinib for Patients With Metastatic Uveal Melanoma PHASE1 Single arm study with dose escalation Phase Ib cohort followed by a Phase I...
Show More Location
HealthPartners Institute Regions Cancer Care Center
Learn More & Join Trial
A Performance and Bioavailability Study of Entrectinib in Healthy Volunteers. PHASE1 This study will evaluate the bioavailability, palatability, safety and tole...
Show More Location
Quotient Clinical Ltd, Clinical Research Unit
Learn More & Join Trial
SMMART Adaptive Clinical Treatment (ACT) Trial EARLY_PHASE1 SMMART-ACT is a feasibility pilot study to determine if testing samples fro...
Show More Location
Multiple Locations
Learn More & Join Trial
KPMNG Study of MOlecular Profiling Guided Therapy Based on Genomic Alterations in Advanced Solid Tumors II N/A A national, prospective, multi-center, open-label, multi-cohort study compr...
Show More Location
Soonchunhyang University Hospital Bucheon
Learn More & Join Trial
Neoadjuvant Study of Targeting ROS1 in Combination With Endocrine Therapy in Invasive Lobular Carcinoma of the Breast (ROSALINE) PHASE2 Despite different clinical characteristics including the response to treatm...
Show More Location
Institut Jules Bordet
Learn More & Join Trial
Genetic Testing in Guiding Treatment for Patients With Brain Metastases PHASE2 This phase II trial studies how well genetic testing works in guiding treat...
Show More Status
Active Not Recruiting
Location
Anchorage Associates in Radiation Medicine
Learn More & Join Trial